Infection of aortoiliac endografts is, to date, a rare complication of endovascular surgery. Staphylococcus species are the most common responsible pathogens, just as in cases with infected grafts after open aortic surgery. We report a case of a 65-year-old man with a history of diabetes mellitus and bladder cancer who developed stent-graft infection 3 years after endovascular treatment for a 5.6 cm abdominal aortic aneurysm. The diagnosis of endograft infection was established radiologically by computed tomographic scans. After intravenous administration of antibiotics and fluids to improve his clinical condition, the patient underwent surgical excision of the infected prosthesis and a bifurcated rifampicin-impregnated Dacron graft was placed in situ. Cultures from the purulent fluid around the aorta and from the endograft revealed development of Candida albicans. To our knowledge, this is the first case of an infected endograft due to a fungus. The patient died from septic shock 3 days postoperatively in the intensive care unit.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.avsg.2006.05.005DOI Listing

Publication Analysis

Top Keywords

infection aortoiliac
8
fungal infection
4
endograft
4
aortoiliac endograft
4
endograft case
4
case report
4
report review
4
review literature
4
literature infection
4
aortoiliac endografts
4

Similar Publications

Spontaneous non-aneurysmal aortic rupture is rare and is usually attributed to penetrating aortic ulcers, infections, tumor infiltrations, or inflammatory and collagen diseases. Chronic rupture is infrequent but extremely rare in non-aneurysmal aortas, which makes diagnosis difficult because the absence of an aneurysm can mislead the physician to rule out rupture. Here, we describe the case of an 85-year-old male, who was undergoing oncological investigation for weight loss, inappetence, and back pain.

View Article and Find Full Text PDF
Article Synopsis
  • This review evaluated the effectiveness and safety of bifurcated endografts for treating aortoiliac disease (AOID) by analyzing multiple studies across various databases.* -
  • Ten studies involving 365 patients primarily used the AFX endograft, showing high primary patency rates at 12, 24, and 36 months, with estimates around 90-94% and low rates of major complications.* -
  • While the initial findings suggest that bifurcated endografts are a promising option for AOID treatment, further research is needed to conclusively determine their long-term efficacy and safety.*
View Article and Find Full Text PDF

Loeys-Dietz syndrome (LDS) has been associated with multiple vascular abnormalities involving the entire arterial tree. However, limited reports regarding compromise in the aortoiliac and femoral bifurcation are available. Further, recommendations for optimal approach, thresholds for diameter at the time of surgery, and surveillance are also limited.

View Article and Find Full Text PDF

Background, establishment and initial experiences of the Danish cardiovascular homograft biobank.

Cell Tissue Bank

September 2024

Department of Cardiothoracic and Vascular Surgery T, Odense University Hospital, J.B. Winsløws Vej 4, 5000, Odense C, Denmark.

Odense University Hospital is a major tertiary vascular hospital in Scandinavia, performing approx. 200 aortic repairs annually. This article presents the rationale behind this endeavor and the early outcomes of the initial implantation of locally processed homografts.

View Article and Find Full Text PDF

Contemporary Experience of the Neo-Aortoiliac System (NAIS) Procedure: A Case Series with Review of the Literature.

Ann Vasc Surg

December 2024

Charles E. Schmidt College of Medicine at Florida Atlantic University, Boca Raton, FL; Department of Vascular Surgery, Boca Raton Regional Hospital, Boca Raton, FL. Electronic address:

Article Synopsis
  • Aortic graft infection (AGI) is a serious condition that can lead to severe complications, making the NAIS procedure a potential reconstruction option after graft removal.
  • A study reviewed 14 patients undergoing the NAIS procedure at a single center from 2010 to 2022, finding a 30-day mortality of 21% and a 64.3% overall complication rate during a mean follow-up of 22 months.
  • A systematic review of the literature revealed a broader analysis of 368 patients, indicating a lower combined 30-day mortality of 9% and re-intervention rates of around 20.5%, suggesting variable outcomes depending on the context and patient population.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!